BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9628428)

  • 21. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
    Pine SR; Wiemels JL; Jayabose S; Sandoval C
    Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia.
    Drunat S; Olivi M; Brunie G; Grandchamp B; Vilmer E; Bièche I; Cavé H
    Br J Haematol; 2001 Aug; 114(2):281-9. PubMed ID: 11529845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.
    Loh ML; Goldwasser MA; Silverman LB; Poon WM; Vattikuti S; Cardoso A; Neuberg DS; Shannon KM; Sallan SE; Gilliland DG
    Blood; 2006 Jun; 107(11):4508-13. PubMed ID: 16493009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEL/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group.
    Zuna J; Hrusák O; Kalinová M; Muzíková K; Starý J; Trka J
    Leukemia; 1999 Jan; 13(1):22-4. PubMed ID: 10049055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
    de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
    Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
    Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
    Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup.
    Rubnitz JE; Behm FG; Wichlan D; Ryan C; Sandlund JT; Ribeiro RC; Rivera GK; Hancock ML; Relling MV; Evans WE; Pui CH; Downing JR
    Leukemia; 1999 Jan; 13(1):19-21. PubMed ID: 10049054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region.
    Iqbal Z
    Asian Pac J Cancer Prev; 2014; 15(8):3541-6. PubMed ID: 24870754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of TEL-AML1 fusion gene in childhood B-lineage acute lymphoblastic leukemia].
    Niu C; Huang W; Su X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):61-4. PubMed ID: 11601199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TEL/AML1 and immunoreceptor gene rearrangements-which comes first?
    Zuna J; Krejci O; Madzo J; Fronkova E; Sramkova L; Hrusak O; Kalina T; Vaskova M; Stary J; Trka J;
    Leuk Res; 2005 Jun; 29(6):633-9. PubMed ID: 15863202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of TEL-AML1 transcripts as a diagnostic tool and for monitoring of minimal residual disease in B-lineage childhood acute lymphoblastic leukemia.
    Park HJ; Lee KE; Um JM; Choe SY; Chi XZ; Lee JA; Shin HY; Ahn HS; Bae SC
    Mol Cells; 2000 Feb; 10(1):90-5. PubMed ID: 10774753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
    Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
    Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
    Kanerva J; Saarinen-Pihkala UM; Niini T; Riikonen P; Möttönen M; Mäkipernaa A; Salmi TT; Vettenranta K; Knuutila S
    Pediatr Blood Cancer; 2004 Jan; 42(1):30-5. PubMed ID: 14752791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frequency of TEL/AML1 and BCR/ABL fusion genes in children with acute lymphoblastic leukemia].
    Artigas A CG; Cabrera C ME; Melo A A; Páez F E; Arriagada M M; Astete A C; Roa E I; Roa S JC
    Rev Med Chil; 2006 Nov; 134(11):1367-76. PubMed ID: 17277849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. The Pediatric Hematology Working Group in the Czech Republic.
    Hrusák O; Trka J; Zuna J; Housková J; Bartůnková J; Starý J
    Leukemia; 1998 Jul; 12(7):1064-70. PubMed ID: 9665191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
    Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
    Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.